Wang Jie, You Wenjun, Jing Zhaohai, Wang Robin, Fu Zhengju, Wang Yangang
Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Department of Endocrinology, Jining No 1 People's Hospital, Jining, 272000, China.
Int Orthop. 2016 Jun;40(6):1299-307. doi: 10.1007/s00264-016-3146-y. Epub 2016 Mar 31.
The relationship between diabetes and risk of fracture has been reported differently in study design and risk estimates, and the relationship between diabetes and risk of vertebral fracture remained unclear. Therefore, we performed a meta-analysis of prospective or retrospective cohort studies to assess the potential relationship between diabetes and vertebral fracture.
We searched medical databases for prospective or retrospective cohort studies on the association between diabetes and vertebral fracture risk. Pooled relative risks (RR) and corresponding 95 % confidence intervals (95 % CI) were calculated with a random-effects model of meta-analysis.
Meta-analysis of eight studies showed that the pooled RR of vertebral fracture for diabetic individuals was 2.03 (95 % CI 1.60-2.59; p < 0.0001). Subgroup analysis by gender showed that the corresponding RRs for male and female were 2.70 (95 % CI 1.34-5.43; p = 0.005) and 1.93 (95 % CI 1.18-3.13; p = 0.008), respectively. Subgroup analysis by study design showed that the corresponding RRs for prospective design and retrospective design were 1.81 (95 % CI 1.19-2.75; p = 0.006) and 2.23 (95 % CI 1.60-3.10; p < 0.0001), respectively. Subgroup analysis by time of follow-up showed that the RR of vertebral fracture for patients with >20 and <20 years of follow-up were 2.23 (95 % CI 1.98-3.62; p < 0.0001) and 1.67 (95 % CI 1.29-2.16; p < 0.0001), respectively.
Diabetes is an independent risk factor for vertebral fracture, primarily being due to diabetic osteoporosis.
糖尿病与骨折风险之间的关系在研究设计和风险评估方面报道各异,且糖尿病与椎体骨折风险之间的关系仍不明确。因此,我们进行了一项前瞻性或回顾性队列研究的荟萃分析,以评估糖尿病与椎体骨折之间的潜在关系。
我们在医学数据库中检索关于糖尿病与椎体骨折风险关联的前瞻性或回顾性队列研究。采用荟萃分析的随机效应模型计算合并相对风险(RR)及相应的95%置信区间(95%CI)。
八项研究的荟萃分析表明,糖尿病患者椎体骨折的合并RR为2.03(95%CI 1.60 - 2.59;p < 0.0001)。按性别进行的亚组分析显示,男性和女性的相应RR分别为2.70(95%CI 1.34 - 5.43;p = 0.005)和1.93(95%CI 1.18 - 3.13;p = 0.008)。按研究设计进行的亚组分析显示,前瞻性设计和回顾性设计的相应RR分别为1.81(95%CI 1.19 - 2.75;p = 0.006)和2.23(95%CI 1.60 - 3.10;p < 0.0001)。按随访时间进行的亚组分析显示,随访时间>20年和<20年患者的椎体骨折RR分别为2.23(95%CI 1.98 - 3.62;p < 0.0001)和1.67(95%CI 1.29 - 2.16;p < 0.0001)。
糖尿病是椎体骨折的独立危险因素,主要归因于糖尿病性骨质疏松症。